Arca
Skip to content
Tools
Tools

Polyangitis

Drug research and approvals for polyangitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 76 studies of polyangitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 76
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 76 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Feb 13, 2025Safe effective therapy with low-dose glucocorticoid in anca-associated vasculitis (safe-low) trialCyclophosphamide / prednisoneOttawa Hospital Research InstituteOngoing
Apr 24, 2024A randomized, controlled study to evaluate lnp023 (iptacopan) in patients with active anca-associated vasculitisIptacopan (LNP023)Novartis PharmaceuticalsClosed
Jun 2, 202252-week, randomized, double-blind, double-dummy, parallel-group, multi-centre, non-inferiority study to investigate the efficacy and safety of depemokimab…DepemokimabGSKClosed
Aug 21, 2019A randomised, double-blind, active-controlled 52-week study with an open-label extension to evaluate the efficacy and safety of benralizumab compared to…Benralizumab (MEDI-563)AstraZeneca PharmaceuticalsOngoing
May 7, 2015"abatacept (ctla4-ig) for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (wegener's) (abrogate)."OrenciaUniversity Of South FloridaOngoing
Mar 9, 2015Mepolizumab long-term access programme for subjects who participated in study mea115921 (placebo-controlled study of mepolizumab in the treatment of…SB240563 (mepolizumab)GSKClosed
Nov 27, 2014A phase IIa, international, multicenter, open-label, uncontrolled study to evaluate the safety and pharmacokinetics of 4x 375 mg/m2 intravenous rituximab in…RituxanRocheClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.